Monday, March 16, 2015 4:33:25 AM
PPCH is trading so cheap because it hasn't generated any real revenue. But, if you think about it, this current pps is not really that cheap and the share price reflects all the steps Propanc has taken to get to the FDA approval meeting, including patent licensing, a huge financing arrangement for 5 million that feel through, forming solid academic partnerships, and before that, bringing on to their scientific board, some of the best cancer researchers and drug developers in the world. It is currently trading on pure potential, but the stock market is a forward moving mechanism, and based on my DD, this potential will be realized as Propanc is poised for success. Do what you will with your shares and do your own DD, I am not trying to convince you that PPCH is gonna be a big winner$$$
FEATURED Fifty 1 Labs, Inc. Announces Major Strategic Advancements and Shareholder Updates • Jun 14, 2024 2:07 AM
ECGI Holdings Announces LOI to Acquire Pacific Saddlery to Capitalize on $12.72 Billion Market Potential • ECGI • Jun 13, 2024 9:50 AM
Snakes & Lattes Opens Pop-Up Location at The Wellington Market in Toronto: A New Destination for Fun and Games - Thanks 'The Well', PepsiCo, Indie Pale House & All Sponsors & Partners for Their Commitment & Assistance Throughout The Process • FUNN • Jun 13, 2024 8:18 AM
HealthLynked Introduces Innovative Online Medical Record Request Form Using DocuSign • HLYK • Jun 12, 2024 8:00 AM
Ubiquitech Software Corp (OTC:UBQU) Posts $624,585 Quarterly Revenue - Largest Quarter Since 2018 • UBQU • Jun 11, 2024 10:13 AM
Element79 Gold Corp Files for OTCQB Uplisting, Provides Financial Update • ELEM • Jun 11, 2024 9:25 AM